Effect of Interferon-gamma 1-b on Innate Immune Cells
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 22 Sep 2017
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Chronic granulomatous disease
- Focus Pharmacodynamics
- 18 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 22 Nov 2016 Status changed from not yet recruiting to recruiting.
- 02 Jun 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jul 2016.